Free Trial

Zura Bio (ZURA) News Today

Zura Bio logo
$2.86 -0.02 (-0.69%)
(As of 11:03 AM ET)
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Buy" from Brokerages
Shares of Zura Bio Limited (NASDAQ:ZURA - Get Free Report) have been given an average recommendation of "Buy" by the seven analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation
Zura Bio Limited (NASDAQ:ZURA) Short Interest Up 183.4% in November
Zura Bio Limited stock logo
Braidwell LP Buys New Position in Zura Bio Limited (NASDAQ:ZURA)
Braidwell LP bought a new stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 2,472,806 shares of the company's stock, valued at approximately $10,040,000. Braidwell LP owned approximately 3.68% of Zura Bio
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Short Interest Update
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 4,960,000 shares, a growth of 183.4% from the October 31st total of 1,750,000 shares. Currently, 10.6% of the shares of the company are sold short. Based on an average trading volume of 444,500 shares, the short-interest ratio is currently 11.2 days.
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) is Great Point Partners LLC's 10th Largest Position
Great Point Partners LLC trimmed its position in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 29.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,263,672 shares of the company's stock after selling 1
Zura Bio Limited stock logo
HC Wainwright Reaffirms "Neutral" Rating for Zura Bio (NASDAQ:ZURA)
HC Wainwright reissued a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a report on Monday.
Zura Bio submits protocol to FDA for Phase 2 study of Tibulizumab
Zura Bio Limited stock logo
Q3 Earnings Forecast for Zura Bio Issued By HC Wainwright
Zura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright raised their Q3 2025 earnings per share estimates for Zura Bio in a report released on Monday, November 11th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of ($0.23) per share
Zura Bio Limited stock logo
Zura Bio's (ZURA) Neutral Rating Reaffirmed at HC Wainwright
HC Wainwright restated a "neutral" rating and set a $5.00 target price on shares of Zura Bio in a research note on Monday.
Zura Bio Limited stock logo
Chardan Capital Has Lowered Expectations for Zura Bio (NASDAQ:ZURA) Stock Price
Chardan Capital reduced their price target on Zura Bio from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Friday.
Zura Bio Limited: Q3 2024 Financial Insights and Strategic Progress
Zura Bio Limited stock logo
Q3 Earnings Forecast for Zura Bio Issued By Leerink Partnrs
Zura Bio Limited (NASDAQ:ZURA - Free Report) - Analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for shares of Zura Bio in a report released on Monday, November 4th. Leerink Partnrs analyst F. Khurshid anticipates that the company will earn ($0.14) per share for the qu
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Receives Average Rating of "Moderate Buy" from Brokerages
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the
Zura Bio Limited stock logo
Zura Bio (NASDAQ:ZURA) Rating Increased to Strong-Buy at Leerink Partnrs
Leerink Partnrs raised Zura Bio to a "strong-buy" rating in a report on Monday.
Zura Bio initiated with an Outperform at Leerink
Zura Bio Limited stock logo
Leerink Partners Begins Coverage on Zura Bio (NASDAQ:ZURA)
Leerink Partners began coverage on shares of Zura Bio in a research report on Monday. They set an "outperform" rating and a $15.00 price target on the stock.
Zura Bio Limited stock logo
Zura Bio's (ZURA) "Neutral" Rating Reaffirmed at HC Wainwright
HC Wainwright reissued a "neutral" rating and issued a $5.00 target price on shares of Zura Bio in a research note on Monday.
Bullish Zura Bio Insiders Loaded Up On US$1.01m Of Stock
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Sees Significant Growth in Short Interest
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,860,000 shares, a growth of 118.9% from the September 15th total of 849,700 shares. Approximately 4.4% of the shares of the company are sold short. Based on an average trading volume of 473,800 shares, the short-interest ratio is currently 3.9 days.
Zura Bio Limited stock logo
Point72 Asset Management L.P. Makes New Investment in Zura Bio Limited (NASDAQ:ZURA)
Point72 Asset Management L.P. purchased a new stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,413,127 shares of the company's stock, valued at approximatel
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Sees Large Increase in Short Interest
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 849,700 shares, a growth of 28.1% from the August 31st total of 663,300 shares. Based on an average daily volume of 471,000 shares, the short-interest ratio is presently 1.8 days. Approximately 2.0% of the company's shares are short sold.
Zura Bio Limited stock logo
Armistice Capital LLC Buys 876,000 Shares of Zura Bio Limited (NASDAQ:ZURA)
Armistice Capital LLC raised its stake in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 53.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,524,000 shares of the company's stock after
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLC
Affinity Asset Advisors LLC trimmed its stake in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) by 50.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 223,335 shares of the company's stock after selling 226,674 sha
Athanor Capital, LP Adjusts Stake in Zura Bio Ltd
Zura Bio Limited stock logo
Great Point Partners LLC Purchases 1,884,501 Shares of Zura Bio Limited (NASDAQ:ZURA)
Great Point Partners LLC increased its holdings in Zura Bio Limited (NASDAQ:ZURA - Free Report) by 68.3% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,642,241 shares of the company's stock after buying an additional 1,884,501 sh
Zura Bio Limited stock logo
Zura Bio (NASDAQ:ZURA) Receives "Overweight" Rating from Piper Sandler
Piper Sandler reaffirmed an "overweight" rating and issued a $26.00 target price on shares of Zura Bio in a research note on Thursday.
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Sees Significant Drop in Short Interest
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totalling 663,300 shares, a decline of 83.5% from the August 15th total of 4,020,000 shares. Based on an average daily volume of 318,200 shares, the short-interest ratio is currently 2.1 days. Currently, 2.0% of the shares of the stock are short sold.
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Expected to Earn Q3 2024 Earnings of ($0.18) Per Share
Zura Bio Limited (NASDAQ:ZURA - Free Report) - Research analysts at HC Wainwright issued their Q3 2024 EPS estimates for shares of Zura Bio in a report issued on Thursday, September 5th. HC Wainwright analyst M. Kapoor expects that the company will post earnings per share of ($0.18) for the quart
Zura Bio Limited stock logo
Zura Bio Limited (NASDAQ:ZURA) Director Sells $200,187.36 in Stock
Zura Bio Limited (NASDAQ:ZURA - Get Free Report) Director Someit Sidhu sold 51,728 shares of the firm's stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $3.87, for a total value of $200,187.36. Following the completion of the transaction, the director now directly owns 2,085,418 shares of the company's stock, valued at $8,070,567.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Zura Bio Limited stock logo
Zura Bio (NASDAQ:ZURA) Receives New Coverage from Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Zura Bio in a research report on Thursday. They issued a "neutral" rating and a $5.00 price target on the stock.
Zura Bio Limited stock logo
FY2024 EPS Estimates for Zura Bio Limited (NASDAQ:ZURA) Decreased by Analyst
Zura Bio Limited (NASDAQ:ZURA - Free Report) - Stock analysts at Chardan Capital reduced their FY2024 EPS estimates for Zura Bio in a research report issued on Tuesday, August 13th. Chardan Capital analyst D. Gataulin now forecasts that the company will post earnings per share of ($0.80) for the
Zura Bio Limited stock logo
Zura Bio (NASDAQ:ZURA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
Zura Bio (NASDAQ:ZURA - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.02).
Get Zura Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter.

⭕ [URGENT] Buy Alert just triggered (Ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

ZURA Media Mentions By Week

ZURA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZURA
News Sentiment

-0.54

0.69

Average
Medical
News Sentiment

ZURA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZURA Articles
This Week

1

2

ZURA Articles
Average Week

Get Zura Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZURA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZURA) was last updated on 12/9/2024 by MarketBeat.com Staff
From Our Partners